Gaceta Médica de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Gaceta Médica de México >Year 2013, Issue 5

Santana D, Sandoval L, González G, Haro R, Ramírez Y, Jiménez PF
Effect of posteroventral pallidotomy on event-related P300 in Parkinson’s disease
Gac Med Mex 2013; 149 (5)

Language: Español
References: 20
Page: 486-491
PDF: 81.87 Kb.

Full text


Background: Ablative procedures are still frequent for the surgical treatment of Parkinson’s disease (PD). Although the P300 component has been used to assess cognitive changes induced by levodopa and deep brain stimulation (DBS), the effects caused by unilateral pallidotomy remain unknown. Material and methods: P300 amplitude and latency in 10 PD patients who underwent unilateral pallidotomy with and without levodopa treatment were compared with 10 healthy controls. Measurements in patients were performed 6 months before and after surgery while only once in controls, throughout the 6-month lapse between the comparative measurements performed in patients. Results: Statistical differences in P300 amplitude and latency were found between the control and PD groups (p ‹ 0.001). On the other hand, there were no differences between the groups with the use of the levodopa treatment or surgery. Discussion: Lack of statistically significant results after six months of pallidotomy or treatment with levodopa suggests an absence of cognitive impairment. Our results obtained with P300 in which safety of surgical treatment has been assessed in PD are consistent with those of other procedures, such as DBS.

Key words: P300, Pallidotomy, Parkinson’s disease.


  1. Fox SH, Katzenschlager R, Lim SY, et al. Movement disorder society evidence-abased medicine review update: treatments for the motor symptoms of Parkinson’s disease. Mov Disord. 2011;26(Suppl):3.

  2. Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder societysponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;15:2129-70.

  3. Smeding HM, Esselink RA, Schmand B, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD. A comparison of neuropsychological effects. J Neurol. 2005;252(2):176-82.

  4. Matsui H, Nishinaka K, Oda M, Kubori T, Udaka F. Auditory event-related potential in Parkinson’s disease: prominent correlation with attention. Parkinsonism Relat Disord. 2007;13:394-8.

  5. Chen KJ, Lin RT, Liu CK, Tai CT, Lai CL. Relationship between eventrelated potentials and frontal-subcortical dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12:453-8.

  6. Morita K, Shoji H, Yamamoto H, et al. Characteristics of cognitive function in patients with Parkinson’s disease: a comparison with healthy subjects. Int Congr Ser. 2005;1278:344-7.

  7. Polich J, Alexander JE, Bauer LO, et al. P300 topography of amplitude/ latency correlations. Brain Topogr. 1997;9(4):275-82.

  8. Naskar S, Sood SK, Goyal V. Effect of acute deep brain stimulation of the subthalamic nucleus on auditory event-related potentials in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:256-60.

  9. Kovacs N, Balas I, Kellenyi L, et al. The impact of bilateral subthalamic deep brain stimulation on long-latency even-related potentials. Parkinsonism Relat Disord. 2008;14:476-80.

  10. Gerschlager W, Bloem BR, Alexh F, Lang W, Deecke L, Cunnington R. Bilateral subthalamic nucleus stimulation does not improve prolonged P300 latencies in Parkinson’s disease. J Neurol. 2001;248:285-9.

  11. Kok A. Age-related changes in involuntary and voluntary attention as reflected in components of the even-related potential (ERP). Biol Psychol. 2000;54:107-43.

  12. Czigler I, Csibra G, Ambro A. Aging, stimulus identification and the effect of probability: an event-related potential study. Biol Psychol. 1996;46:27-40.

  13. Wang L, Kuroiwa Y, Kamitani T. Visual event-related potential changes at two different tasks in nondemented Parkinson’s disease. J Neurol Sci. 1999;164(2):139-47.

  14. Polich J. Clinical applications of the P300 event-related brain potential. Phys Med Rehab Clin N Am. 2004;15:133-61.

  15. Rektor I, Bares M, Kanovsky P, et al. Cognitive potentials in the basal galglia-frontocortical circuits. An intracerebral recording study. Exp Brain Res. 2004;158:289-301.

  16. Polich J. Updating P300: an integrative theory of P300a and P300b. Clin Neurophysiol. 2007;118:2128-48.

  17. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-81.

  18. Graybiel AM. The basal ganglia and cognitive pattern generators. Schizophr Bull. 1997;23(3):459-69.

  19. Joel DJ. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to clinical syndrome of Huntington’s disease. Mov Disord. 2001;16(3):407-23.

  20. Middleton F, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev. 2000;31:236-50.

>Journals >Gaceta Médica de México >Year 2013, Issue 5

· Journal Index 
· Links 

Copyright 2019